Investment Thesis
Morgan Stanley Direct Lending Fund exhibits deteriorating fundamentals with net income declining 43.4% YoY and negative ROE of -0.3%, indicating the fund is currently unprofitable despite a substantial asset base. The combination of accelerating losses, elevated leverage at 1.21x debt-to-equity, and minimal cash reserves relative to total assets presents significant risk in a challenging lending environment.
Strengths
- Positive operating cash flow of $86.3M demonstrates underlying portfolio cash generation despite negative earnings
- Substantial asset base of $3.8B provides diversification across direct lending portfolio
- Debt-to-equity ratio of 1.21x shows leverage is not excessive relative to peer lending funds
Risks
- Accelerating losses with net income down 43.4% YoY and negative ROE of -0.3% indicate fund is destroying shareholder value
- High leverage combined with deteriorating profitability creates vulnerability to credit losses and market stress
- Cash position of $80.7M is only 2.1% of total assets, providing limited liquidity buffer for portfolio stress events
Key Metrics to Watch
- Net investment income trends and portfolio yield as interest rate environment stabilizes
- Credit quality metrics and default/loss rates within the direct lending portfolio
- Leverage ratio maintenance and debt refinancing costs in tightening credit markets
Financial Metrics
Revenue
N/A
Net Income
-4.5M
EPS (Diluted)
$-0.05
Free Cash Flow
86.3M
Total Assets
3.8B
Cash
80.7M
Profitability Ratios
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
ROE
-0.3%
ROA
-0.1%
FCF Margin
N/A
Balance Sheet & Liquidity
Current Ratio
N/A
Quick Ratio
N/A
Debt/Equity
1.21x
Debt/Assets
55.8%
Interest Coverage
N/A
Long-term Debt
2.1B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-09T11:56:46.402799 |
Data as of: 2026-03-31 |
Powered by Claude AI